Pathogenesis, symptoms and therapy of type-1 diabetes mellitus
Gero, L.ás.ó
Orvosi Hetilap 145(46): 2339-2343
2004
ISSN/ISBN: 0030-6002 PMID: 16106906 Document Number: 575748
Document emailed within 1 workday
Related Documents
Kadowaki, T. 1999: Molecular pathogenesis of type 2 diabetes mellitus Seikagaku. Journal of Japanese Biochemical Society 71(11): 1281-1298Vilsbøll, T.; Knop, F.K. 2007: Effect of incretin hormones GIP and GLP-1 for the pathogenesis of type 2 diabetes mellitus Ugeskrift for Laeger 169(22): 2101-2105
Liang, H.; Liang, Y.-z.; Chen, H.; Yu, Z.-q.; Su, J.-h.; Wu, Z.-b.; Qin, J.-y. 2003: Role of cytomegalovirus infection in the pathogenesis of type 2 diabetes mellitus Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 17(4): 351-353
Uhl, D. 1987: Diabetes mellitus. Pathogenesis, complications and therapy Medizinische Monatsschrift für Pharmazeuten 10(10): 318-323
DeWitt, D.E.; Hirsch, I.B. 2003: Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review JAMA 289(17): 2254-2264
Gasińska, T.; Drózdz, M.; Izbicka, M.; Wawrzyniak, L. 1989: Hypercalciuria in patients with diabetes mellitus type 1 and 2--studies of its pathogenesis using the oral calcium tolerance test Endokrynologia Polska 40(3): 115-124
Reimers, J.I. 1998: Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus? Danish Medical Bulletin 45(2): 157-180
Genes, V.S.; Genes, S.G. 1993: Etiology, pathogenesis and approaches to pathogenetic therapy of noninsulin-dependent diabetes mellitus Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 3: 54-58
Winkler, G.áb. 2003: Therapy of adult type-2 diabetes mellitus Orvosi Hetilap 144(44): 2179-2183
Sánchez Sánchez, O.; Sabán Ruiz, Jé. 2008: Lights and shades in the application of new guidelines for the management of type 2 diabetes mellitus. Practical advice about combined therapy and insulin therapy Medicina Clinica 130(5): 188-196
Schmeidl, R.; Teuber, J.; Paschke, R.; Schwedes, U.; Usadel, K.H. 1986: Immune modulation therapy in type i diabetes mellitus Fortschritte der Medizin 104(45): 879-883
Boyce, J.M. 1995: Dietary therapy in type II diabetes mellitus: correction JAMA 274(8): 612
KazeÄ, N.S.; Granovskaia-Tsvetkova, A.M. 1992: Oral therapy of patients with type Ii diabetes mellitus Problemy Endokrinologii 38(2): 46-48
Chantelau, E. 1986: Sugar substitutes in the diet therapy of type i diabetes mellitus Deutsche Medizinische Wochenschrift 111(31-32): 1220-1222
Sahay, B.K. 2011: Insulin therapy at onset of type 2 diabetes mellitus--a new concept Journal of the Association of Physicians of India 59 Suppl: 13-15
Rausch, R. 2014: Diabetes mellitus type 1 and 2. Flexible therapy with insulin degludec Medizinische Monatsschrift für Pharmazeuten 37(7): 273-274
Patel, A.; Patro, S.; Mishra, S.; Patel, A. 2020: Autoimmune Type 1 Diabetes Mellitus and Autoimmune Thyroiditis - a rare sequelae of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Journal of the Association of Physicians of India 68(1): 50
Verspohl, E.J. 2014: Diabetes mellitus type 2 the status of future therapy with GPR40 agonists Medizinische Monatsschrift für Pharmazeuten 37(7): 275
Schernthaner, G.; Aschauer-Treiber, G.; Gaube, S.; Klösch-Kasparek, D.; Müller, C.; Zielinski, C. 1988: Results of cyclosporin a therapy in the early phase of type i diabetes mellitus Wiener Klinische Wochenschrift 100(13): 454-459
Dakhli, S.; Lamine, S.; Lamine, F.; Trabelsi, N.; Aouididi, F.; Zouaoui, C.; Mami, F.Ben.; Achour, A. 2007: Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy La Tunisie Medicale 85(11): 945-950